Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated:  7/22/2013
Clinical Research Facility
mi
from
Orlando, FL
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated: 7/22/2013
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated:  7/22/2013
Clinical Research Facility
mi
from
Atlanta, GA
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated: 7/22/2013
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated:  7/22/2013
Clinical Research Facility
mi
from
Coeur D'Alene, ID
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated: 7/22/2013
Clinical Research Facility
mi
from
Coeur D'Alene, ID
Click here to add this to my saved trials
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated:  7/22/2013
Clinical Research Facility
mi
from
Oak Brook, IL
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated: 7/22/2013
Clinical Research Facility
mi
from
Oak Brook, IL
Click here to add this to my saved trials
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated:  7/22/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated: 7/22/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated:  7/22/2013
Clinical Research Facility
mi
from
Las Vegas, NV
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated: 7/22/2013
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated:  7/22/2013
Clinical Research Facility
mi
from
Winston-Salem, NC
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated: 7/22/2013
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated:  7/22/2013
Clinical Research Facility
mi
from
Columbus, OH
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated: 7/22/2013
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated:  7/22/2013
Clinical Research Facility
mi
from
Austin, TX
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated: 7/22/2013
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated:  7/22/2013
Clinical Research Facility
mi
from
Bellevue, WA
Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
A Long-Term Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aripiprazole (OPC 14597) as Maintenance Treatment in Adolescent Patients With Schizophrenia
Status: Enrolling
Updated: 7/22/2013
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  7/24/2013
CNRI-San Diego
mi
from
San Diego, CA
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 7/24/2013
CNRI-San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  7/24/2013
Comprehensive Clinical Development
mi
from
Washington,
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 7/24/2013
Comprehensive Clinical Development
mi
from
Washington,
Click here to add this to my saved trials
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  7/24/2013
Community Clinical Research
mi
from
Austin, TX
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
An Open-label, Multiple Dose, Safety and Tolerability Study of Aripiprazole IM Depot Administered in the Deltoid Muscle in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 7/24/2013
Community Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
The Metabolic Syndrome in Patients With Schizophrenia
Status: Enrolling
Updated:  8/6/2013
VA San Diego Healthcare System
mi
from
San Diego, CA
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
The Metabolic Syndrome in Patients With Schizophrenia
Status: Enrolling
Updated: 8/6/2013
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Birmingham, AL
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Fort Smith, AR
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Washington,
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Overland Park, KA
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Metairie, LA
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Jackson, MS
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
New York, NY
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Cleveland, OH
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Charleston, SC
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Dallas, TX
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated:  8/13/2013
Clinical Research Facility
mi
from
Seattle, WA
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia
Status: Enrolling
Updated: 8/13/2013
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
A Phase 1, Open-Label, Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH) Risperidone When Risperidone is Administered From a Polyurethane Implant
Status: Enrolling
Updated:  8/28/2013
CRI Lifetree
mi
from
Marlton, NJ
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
A Phase 1, Open-Label, Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH) Risperidone When Risperidone is Administered From a Polyurethane Implant
Status: Enrolling
Updated: 8/28/2013
CRI Lifetree
mi
from
Marlton, NJ
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Fort Smith, AR
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Fort Smith, AR
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Santa Clara, CA
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Bridgeport, CT
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Washington,
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Decatur, GA
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Park Ridge, IL
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Overland Park, KA
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Metairie, LA
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Baltimore, MD
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Boston, MA
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Jackson, MS
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
St. Joseph, MO
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Henderson, NV
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Henderson, NV
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
Newark, NJ
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated:  8/29/2013
Clinical Research Facility
mi
from
New York, NY
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
A Randomized, Multicenter, Double-Blind, Relapse Prevention Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Subjects With Schizophrenia
Status: Enrolling
Updated: 8/29/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials